Myovant Sciences: Q3 Earnings Insights


Myovant Sciences (NYSE:MYOV) reported its Q3 earnings results on Wednesday, January 26, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.


Myovant Sciences missed estimated earnings by 13.33%, reporting an EPS of $-0.68 versus an estimate of $-0.6, which surprised analysts.

Revenue was up $53.06 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15, which was followed by a 1.31% drop in the share price the next day.

Here’s a look at Myovant Sciences’s past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.38 -0.33 -0.99 -0.85
EPS Actual -0.23 -0.67 -0.89 -0.82
Revenue Estimate 71.40M 57.05M 24.63M 2.17M
Revenue Actual 77.90M 41.06M 24.61M 1.38M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Source link

Leave a Reply

Copyright © 2022 Billionaire Club Co LLC. All rights reserved

Loading the chat ...